Stock explainer / Healthcare / Reviewed 11 October 2026
Johnson & Johnson stock, explained for beginners
The short answer
Johnson & Johnson develops prescription medicines and makes medical devices used in surgery, heart care and eye care.
Investing involves risk and you can lose money. This page explains general ideas; it is not personal financial, tax or investment advice.
How Johnson & Johnson makes money
- Prescription medicines for areas such as cancer and immune diseases
- Medical devices and surgical equipment
- Licensing and partnerships
Main strengths
- A broad range of medicines and devices
- A long history of paying dividends
- Large research and development budget
Main risks
- Patent expiries on major medicines
- Legal claims and regulatory decisions
- Pressure on healthcare prices
Five questions to ask about Johnson & Johnson
These match Mesodian's five core scores. Members see each score, updated, with the factors behind it.
- Quality
- How strong is its balance sheet?
- Growth
- Can new medicines replace those losing patent protection?
- Value
- How does its price compare with its earnings and dividend?
- Sentiment
- How do investors view its pipeline and legal issues?
- Risk
- How exposed is it to lawsuits and pricing rules?
This explainer is general education about a well-known company. It is not a recommendation to buy, sell or hold JNJ. Check the company's latest reports before making decisions.
Keep going
Learn as you invest, with Mesodian.
Lessons, five plain-English scores and a clear view of your portfolio. Research is $9.99 a month; Premium, with broker connection and portfolio tracking, is $14.99.